Type of security: Stock
Sector: Health Care
Industry: Medical/Nursing Services
The data is delayed by 15 minutes.
Description: BioScrip, Inc. provides home infusion and other home care services, and pharmacy benefit management (PBM) services in the United States. It operates in three segments: Infusion Services, Home Health Services, and PBM Services. The Infusion Services segment offers home infusion and respiratory therapy services; and durable medical equipment, products, and services. Its home infusion services include the intravenous administration of medications to treat various acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic conditions, cancer, pain, and palliative care. This segment offers services, including the dispensing and administering of infusion-based drugs, which require nursing support and clinical management services; equipment to administer the dosage; and patient training. The Home Health Services segment provides skilled nursing, wound care, oncology nursing and infusion nursing, medical social services, home health aide services, private duty nursing care,
|Shares Outstanding||EPS||-0.42||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||5.89%||Sales Growth - Q/Q||3.15%||P/E||-6.02|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||-16.78%||ROE||-54.92%||ROI||-22.68%|
|Current Ratio||1.46||Quick Ratio||1.17||Long Term Debt/Equity||6.23||Debt Ratio||0.56|
|Gross Margin||26.08%||Operating Margin||-8.41%||Net Profit Margin||-14.09%||Dividend Payout Ratio|
|Cash From Financing Activities||52.62 M||Cash From Investing Activities||-2.07 M||Cash From Operating Activities||-28.05 M||Gross Profit||66.47 M|
|Net Profit||-19.67 M||Operating Profit||-4.81 M||Total Assets||845.42 M||Total Current Assets||212.35 M|
|Total Current Liabilities||145.16 M||Total Debt||418.83 M||Total Liabilities||587.2 M||Total Revenue||261.68 M|
|High 52 week||4||Low 52 week||1.61||Last close||2.11||Last change||2.43%|
|RSI||62.5||Average true range||0.11||Beta||0.74||Volume||903.26 K|
|Simple moving average 20 days||7.71%||Simple moving average 50 days||0.08%||Simple moving average 200 days||-24.71%|
|Performance Week||5.5%||Performance Month||22.67%||Performance Quart||-41.55%||Performance Half||-29.43%|
|Performance Year||-22.14%||Performance Year-to-date||-45.48%||Volatility daily||3.95%||Volatility weekly||8.84%|
|Volatility monthly||18.11%||Volatility yearly||62.72%||Relative Volume||179.15%||Average Volume||1.66 M|
|New High||New Low|
2020-05-07 17:49:08 | Edited Transcript of BIOS earnings conference call or presentation 7-May-20 12:30pm GMT
2020-03-29 19:02:27 | Is BioScrip Inc. BIOS Relatively A Good Stock To Buy?
2020-03-25 14:45:27 | Edited Transcript of BIOS earnings conference call or presentation 5-Mar-20 1:30pm GMT
2020-02-03 08:30:10 | Option Care Health Completes Reverse Stock Split and Ticker Symbol Change
2019-12-26 16:24:01 | RLH Corporation Appoints R. Carter Pate as Chairman
2019-12-23 14:57:06 | Option Care Health, Inc. BIOS: Are Hedge Funds Right About This Stock?
2019-12-18 09:22:56 | Option Care Health to Participate in the 38th Annual J.P. Morgan Healthcare Conference
2019-12-06 11:31:04 | Option Care BIOS Down 12% Since Last Earnings Report: Can It Rebound?
2019-12-05 08:51:01 | Option Care Health BIOS Surges: Stock Moves 7.3% Higher
2019-11-20 09:36:02 | Option Care is the Preferred Provider of Haemophilia Treatment
2019-11-19 14:14:29 | Option Care Health Selected by Highmark as Preferred Provider of Hemophilia Treatment
2019-11-11 07:50:49 | Is Option Care Health NASDAQ:BIOS Using Too Much Debt?
2019-11-08 07:53:25 | Edited Transcript of BIOS earnings conference call or presentation 6-Nov-19 1:30pm GMT
2019-11-07 11:18:04 | Option Care Health BIOS Q3 Earnings Meet, Revenues Top
2019-11-06 14:46:42 | Is Option Care Health, Inc. BIOS A Good Stock To Buy?
2019-11-06 10:25:03 | Option Care BIOS Reports Q3 Loss, Tops Revenue Estimates
2019-11-06 06:00:00 | Option Care Health Announces Third Quarter Results
2019-10-01 15:06:07 | Learn How to Find Top-Ranked 'Cheap' Stocks Under $10 with this Screener
2019-09-17 10:00:02 | Here's Why Momentum Investors Will Love BioScrip BIOS
2019-09-16 08:38:12 | Moving Average Crossover Alert: Option Care Health
2019-09-12 10:02:02 | Top Ranked Momentum Stocks to Buy for September 12th
2019-08-16 08:26:49 | Why Denver-based Bioscrip decided to merge with a competitor
2019-08-13 17:00:00 | Option Care Health Receives Anticipated Nasdaq Notice
2019-08-08 10:03:02 | BioScrip Closes Option Care Merger, Incurs Wider Q2 Loss
2019-08-07 08:00:00 | Option Care and BioScrip Complete Merger to Form Option Care Health
2019-08-02 12:40:00 | BioScrip Announces Shareholder Approval of Merger with Option Care
2019-07-30 09:45:01 | BioScrip BIOS Reports Q2 Loss, Tops Revenue Estimates
2019-07-30 08:00:00 | BioScrip Reports Second Quarter 2019 Financial Results
2019-07-22 09:00:00 | Leading Independent Proxy Advisory Firms, ISS and Glass Lewis, Recommend that BioScrip Stockholders Vote “FOR” the Transaction Proposals in Connection with the Proposed Merger with Option Care
2019-07-05 12:29:30 | Is BioScrip Inc. BIOS A Good Stock To Buy?
2019-07-02 09:14:01 | BioScrip, Inc. BIOS Shares March Higher, Can It Continue?
2019-06-24 09:29:00 | LogistiCare Announces Leadership Transition
2019-06-18 06:14:10 | BioScrip, Inc.'s Shares March Higher, Can It Continue?
2019-06-10 11:47:37 | RLH Corporation Announces Changes to Its Board of Directors
2019-06-01 09:31:01 | BioScrip BIOS Up 5.2% Since Last Earnings Report: Can It Continue?
2019-05-21 09:00:00 | BioScrip to Participate in Upcoming Investor Conferences
2019-05-09 20:59:39 | Here’s What Hedge Funds Think About BioScrip Inc. BIOS
2019-05-09 10:36:02 | BioScrip's Option Care Merger on Track, Q1 Loss Narrows